Boston Scientific Corporation vs Cognizant Technology Solutions Corp — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Cognizant Technology Solutions Corp trades at $58.28 (market cap $26.40B). The key difference: Boston Scientific Corporation is far larger — about 2.8× Cognizant Technology Solutions Corp's market cap, and Cognizant Technology Solutions Corp pays a 2.25% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | CTSH | |
|---|---|---|
Market Cap | $74.19B | $26.40B |
Sector | Health | Technology |
52-Week High | $108.14 | $86.70 |
52-Week Low | $42.63 | $38.73 |
Enterprise Value | $86.27B | $27.44B |
Dividend Yield | — | 2.25% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →